Andrew Kwon

2.8k total citations · 1 hit paper
5 papers, 2.1k citations indexed

About

Andrew Kwon is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Andrew Kwon has authored 5 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Andrew Kwon's work include Estrogen and related hormone effects (3 papers), Hormonal and reproductive studies (2 papers) and Prostate Cancer Treatment and Research (2 papers). Andrew Kwon is often cited by papers focused on Estrogen and related hormone effects (3 papers), Hormonal and reproductive studies (2 papers) and Prostate Cancer Treatment and Research (2 papers). Andrew Kwon collaborates with scholars based in United States and Poland. Andrew Kwon's co-authors include John Wongvipat, Charles L. Sawyers, Chris Tran, Howard I. Scher, David T. Hung, Yu Chen, Teresa Wasielewska, Tomasz M. Beer, Samedy Ouk and Nicola J. Clegg and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Andrew Kwon

4 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

2009 1.7k citations Chris Tran, Samedy Ouk et al. Science profile →

Peers

Countries citing papers authored by Andrew Kwon

Since Specialization

Citations

This map shows the geographic impact of Andrew Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Kwon more than expected).

Fields of papers citing papers by Andrew Kwon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Kwon. The network helps show where Andrew Kwon may publish in the future.

Co-authorship network of co-authors of Andrew Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Kwon. A scholar is included among the top collaborators of Andrew Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Kwon. Andrew Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Antitumor activity of nab-sirolimus versus mTOR inhibitors temsirolimus, sirolimus, and everolimus in A549 NSCLC xenografts. 2024 ·Journal of Clinical Oncology ·Shihe Hou, (unknown), Andrew Kwon, (unknown)	0
2	Abstract 5484: Synergistic antitumor activity of nab-sirolimus in combination with KRAS inhibitors (KRASis) sotorasib and adagrasib in KRAS G12C NSCLC and bladder cancer xenografts 2023 ·Cancer Research ·Shihe Hou, Andrew Kwon, Jorge J. Nieva, Neil Desai	1
3	Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer breakdown → 2009 ·Science ·Chris Tran, Samedy Ouk, Nicola J. Clegg, Yu Chen, Philip A. Watson, Vivek Arora, John Wongvipat, Peter Smith‐Jones, Dongwon Yoo, Andrew Kwon, Teresa Wasielewska, Derek S. Welsbie, (unknown), Celestia S. Higano, Tomasz M. Beer, David T. Hung, Howard I. Scher, Michael E. Jung, Charles L. Sawyers	1689
4	Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor 2006 ·Proceedings of the National Academy of Sciences ·Xin Li, Michael A. Teitell, Devon A. Lawson, Andrew Kwon, Ingo K. Mellinghoff, Owen N. Witte	128
5	HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability 2004 ·Cancer Cell ·Ingo K. Mellinghoff, Igor Vivanco, Andrew Kwon, Chris Tran, John Wongvipat, Charles L. Sawyers	262

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact